IL-1β can activate microglia and astrocytes, leading to the synthesis of proinflammatory and chemotactic mediators, and perpetuate a variety of CNS diseases including multiple sclerosis, neurodegenerative diseases, traumatic brain injury, and diabetic retinopathy (53). This evidence concerns the gene IL1B and multiple sclerosis.